Biosimilar medications for oncology care improve access to effective treatment at a significant financial savings for health plans, health systems, and patients. First up, just what are biosimilars? Some people wonder if it’s just another term for generics. Biosimilars are not the same as generic versions of medications. Biosimilars are less expensive versions of already approved biologic […]
Multiple sclerosis doesn’t appear out of nowhere. In the few years prior to a diagnosis, people tend to have a handful of symptoms that may serve as a warning sign of trouble ahead. Here’s what happened: a team of researchers at the University of British Columbia set up the largest study of its kind, examining […]
Ongoing health issues tend to come with the need for multiple medications. This is so common that it has a name: polypharmacy. Polypharmacy impacts healthcare spending at both an individual and payer level. But on the patient level, the bigger concern associated with polypharmacy is the potential for drug-drug interactions. Polypharmacy can develop if a […]